Sculptor Capital LP Inovio Pharmaceuticals, Inc. Transaction History

Sculptor Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $2.12 Million - $3.71 Million	-713,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $2.53 Million - $4.08 Million	406,800 Added 132.55%	713,700 $6.62 Million
Q1 2021 May 14, 2021	BUY	$8.81 - $16.96 $1.35 Million - $2.59 Million	152,900 Added 99.29%	306,900 $2.85 Million
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $728,450 - $1.1 Million	-85,700 Reduced 35.75%	154,000 $1.36 Million
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $656,502 - $1.86 Million	-68,600 Reduced 22.25%	239,700 $2.78 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $409,122 - $1.82 Million	57,300 Added 22.83%	308,300 $8.31 Million
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $747,980 - $3.54 Million	251,000 New	251,000 $1.87 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $519M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.